The progress in gene therapy presented a hopeful outlook for the treatment of diverse ocular disorders. Investigating gene-editing techniques, researchers aimed to target genetic mutations associated with conditions such as retinitis pigmentosa and macular degeneration. This focused approach seeked to rectify underlying genetic abnormalities, potentially providing enduring solutions for individuals impacted by hereditary eye diseases.